Business Description
Nutriband Inc
NAICS : 339113
SIC : 2834
ISIN : US67092M2089
Description
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 28.35 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 15.99 | |||||
| Beneish M-Score | -3.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.2 | |||||
| 3-Year EBITDA Growth Rate | -20.4 | |||||
| 3-Year EPS without NRI Growth Rate | -12.2 | |||||
| 3-Year FCF Growth Rate | -117.1 | |||||
| 3-Year Book Growth Rate | -9.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.81 | |||||
| 9-Day RSI | 38.89 | |||||
| 14-Day RSI | 38.8 | |||||
| 3-1 Month Momentum % | 18.13 | |||||
| 6-1 Month Momentum % | -17.84 | |||||
| 12-1 Month Momentum % | 100 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.96 | |||||
| Quick Ratio | 4.83 | |||||
| Cash Ratio | 4.57 | |||||
| Days Inventory | 47.73 | |||||
| Days Sales Outstanding | 21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.7 | |||||
| Shareholder Yield % | -16.39 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.59 | |||||
| Operating Margin % | -298.17 | |||||
| Net Margin % | -338.46 | |||||
| FCF Margin % | -207.73 | |||||
| ROE % | -69.58 | |||||
| ROA % | -59.67 | |||||
| ROIC % | -88.84 | |||||
| 3-Year ROIIC % | 51.41 | |||||
| ROC (Joel Greenblatt) % | -839.62 | |||||
| ROCE % | -65.59 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19.9 | |||||
| PB Ratio | 4.06 | |||||
| Price-to-Tangible-Book | 8.17 | |||||
| EV-to-EBIT | -5.96 | |||||
| EV-to-Forward-EBIT | -14.27 | |||||
| EV-to-EBITDA | -6.23 | |||||
| EV-to-Revenue | 20.07 | |||||
| EV-to-Forward-Revenue | 6.79 | |||||
| EV-to-FCF | -9.54 | |||||
| Price-to-GF-Value | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 9.6 | |||||
| Price-to-Net-Cash | 10.67 | |||||
| Earnings Yield (Greenblatt) % | -16.77 | |||||
| FCF Yield % | -9.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nutriband Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.864 | ||
| EPS (TTM) (€) | -0.655 | ||
| Beta | 2.53 | ||
| 3-Year Sharpe Ratio | 0.33 | ||
| 3-Year Sortino Ratio | 0.63 | ||
| Volatility % | 118.4 | ||
| 14-Day RSI | 38.8 | ||
| 14-Day ATR (€) | 0.210769 | ||
| 20-Day SMA (€) | 4.259 | ||
| 12-1 Month Momentum % | 100 | ||
| 52-Week Range (€) | 2.02 - 8.45 | ||
| Shares Outstanding (Mil) | 11.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nutriband Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nutriband Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nutriband Inc Frequently Asked Questions
What is Nutriband Inc(FRA:9WV)'s stock price today?
The current price of FRA:9WV is €3.84. The 52 week high of FRA:9WV is €8.45 and 52 week low is €2.02.
When is next earnings date of Nutriband Inc(FRA:9WV)?
The next earnings date of Nutriband Inc(FRA:9WV) is 2025-03-04 Est..
Does Nutriband Inc(FRA:9WV) pay dividends? If so, how much?
Nutriband Inc(FRA:9WV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers